Cargando…

Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis

Forty years of research has proven beyond any doubt that p53 is a key regulator of many aspects of cellular physiology. It is best known for its tumor suppressor function, but it is also a regulator of processes important for maintenance of homeostasis and stress response. Its activity is generally...

Descripción completa

Detalles Bibliográficos
Autores principales: Roszkowska, Katarzyna A., Gizinski, Slawomir, Sady, Maria, Gajewski, Zdzislaw, Olszewski, Maciej B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072881/
https://www.ncbi.nlm.nih.gov/pubmed/32079237
http://dx.doi.org/10.3390/ijms21041334
_version_ 1783506509678772224
author Roszkowska, Katarzyna A.
Gizinski, Slawomir
Sady, Maria
Gajewski, Zdzislaw
Olszewski, Maciej B.
author_facet Roszkowska, Katarzyna A.
Gizinski, Slawomir
Sady, Maria
Gajewski, Zdzislaw
Olszewski, Maciej B.
author_sort Roszkowska, Katarzyna A.
collection PubMed
description Forty years of research has proven beyond any doubt that p53 is a key regulator of many aspects of cellular physiology. It is best known for its tumor suppressor function, but it is also a regulator of processes important for maintenance of homeostasis and stress response. Its activity is generally antiproliferative and when the cell is damaged beyond repair or intensely stressed the p53 protein contributes to apoptosis. Given its key role in preventing cancer it is no wonder that it is the most frequently mutated gene in human cancer. Surprisingly, a subset of missense mutations occurring in p53 (gain-of-function) cause it to lose its suppressor activity and acquire new functionalities that turn the tumor suppressor protein into an oncoprotein. A solid body of evidence exists demonstrating increased malignancy of cancers with mutated p53 in all aspects considered “hallmarks of cancer”. In this review, we summarize current findings concerning the cellular processes altered by gain-of-function mutations in p53 and their influence on cancer invasiveness and metastasis. We also present the variety of molecular mechanisms regulating these processes, including microRNA, direct transcriptional regulation, protein–protein interactions, and more.
format Online
Article
Text
id pubmed-7072881
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70728812020-03-19 Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis Roszkowska, Katarzyna A. Gizinski, Slawomir Sady, Maria Gajewski, Zdzislaw Olszewski, Maciej B. Int J Mol Sci Review Forty years of research has proven beyond any doubt that p53 is a key regulator of many aspects of cellular physiology. It is best known for its tumor suppressor function, but it is also a regulator of processes important for maintenance of homeostasis and stress response. Its activity is generally antiproliferative and when the cell is damaged beyond repair or intensely stressed the p53 protein contributes to apoptosis. Given its key role in preventing cancer it is no wonder that it is the most frequently mutated gene in human cancer. Surprisingly, a subset of missense mutations occurring in p53 (gain-of-function) cause it to lose its suppressor activity and acquire new functionalities that turn the tumor suppressor protein into an oncoprotein. A solid body of evidence exists demonstrating increased malignancy of cancers with mutated p53 in all aspects considered “hallmarks of cancer”. In this review, we summarize current findings concerning the cellular processes altered by gain-of-function mutations in p53 and their influence on cancer invasiveness and metastasis. We also present the variety of molecular mechanisms regulating these processes, including microRNA, direct transcriptional regulation, protein–protein interactions, and more. MDPI 2020-02-17 /pmc/articles/PMC7072881/ /pubmed/32079237 http://dx.doi.org/10.3390/ijms21041334 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Roszkowska, Katarzyna A.
Gizinski, Slawomir
Sady, Maria
Gajewski, Zdzislaw
Olszewski, Maciej B.
Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
title Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
title_full Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
title_fullStr Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
title_full_unstemmed Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
title_short Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
title_sort gain-of-function mutations in p53 in cancer invasiveness and metastasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072881/
https://www.ncbi.nlm.nih.gov/pubmed/32079237
http://dx.doi.org/10.3390/ijms21041334
work_keys_str_mv AT roszkowskakatarzynaa gainoffunctionmutationsinp53incancerinvasivenessandmetastasis
AT gizinskislawomir gainoffunctionmutationsinp53incancerinvasivenessandmetastasis
AT sadymaria gainoffunctionmutationsinp53incancerinvasivenessandmetastasis
AT gajewskizdzislaw gainoffunctionmutationsinp53incancerinvasivenessandmetastasis
AT olszewskimaciejb gainoffunctionmutationsinp53incancerinvasivenessandmetastasis